FDA Inspection 1003117 — Shandong Analysis And Test Center

Shandong Analysis And Test Center — FEI 3011060456

The FDA completed an inspection of Shandong Analysis And Test Center on Jan 18, 2017 in Jinan. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jan 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jinan (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.